[go: up one dir, main page]

BR9910981A - Composição e uso da mesma para o tratamento de irritações e infeções epidérmicas - Google Patents

Composição e uso da mesma para o tratamento de irritações e infeções epidérmicas

Info

Publication number
BR9910981A
BR9910981A BR9910981-6A BR9910981A BR9910981A BR 9910981 A BR9910981 A BR 9910981A BR 9910981 A BR9910981 A BR 9910981A BR 9910981 A BR9910981 A BR 9910981A
Authority
BR
Brazil
Prior art keywords
composition
treatment
irritation
infections
stannous fluoride
Prior art date
Application number
BR9910981-6A
Other languages
English (en)
Inventor
William J Embro
Original Assignee
William J Embro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William J Embro filed Critical William J Embro
Publication of BR9910981A publication Critical patent/BR9910981A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO E USO DA MESMA PARA O TRATAMENTO DE IRRITAçõES E INFECçõES EPIDéRMICAS". Uma composição de fluoreto de estanho é descrita. A composição compreende fluoreto de estanho e pelo menos um composto contendo zinco. Os compostos contendo zinco estabilizaram e evitaram a hidrólise dos íons de estanho resultando em uma composição de fluoreto de estanho mais eficaz para uso no tratamento de irritações e infecções epidérmicas.
BR9910981-6A 1998-06-09 1999-06-09 Composição e uso da mesma para o tratamento de irritações e infeções epidérmicas BR9910981A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8856098P 1998-06-09 1998-06-09
PCT/US1999/013048 WO1999063816A1 (en) 1998-06-09 1999-06-09 Method and composition for the treatment of epidermal irritations and infections

Publications (1)

Publication Number Publication Date
BR9910981A true BR9910981A (pt) 2004-08-03

Family

ID=22212082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910981-6A BR9910981A (pt) 1998-06-09 1999-06-09 Composição e uso da mesma para o tratamento de irritações e infeções epidérmicas

Country Status (16)

Country Link
US (2) US6605289B1 (pt)
EP (1) EP1085804B1 (pt)
JP (1) JP2002517411A (pt)
CN (1) CN1311628A (pt)
AT (1) ATE424109T1 (pt)
AU (1) AU760870B2 (pt)
BR (1) BR9910981A (pt)
CA (1) CA2334344C (pt)
DE (1) DE69940508D1 (pt)
EA (1) EA003463B1 (pt)
ES (1) ES2323395T3 (pt)
IL (1) IL140095A (pt)
NZ (1) NZ509227A (pt)
TR (1) TR200003674T2 (pt)
WO (1) WO1999063816A1 (pt)
ZA (1) ZA200100137B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043047A1 (en) * 1999-03-26 2004-03-04 Parfums Christian Dior Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of the CD44 membrane receptors of skin cells
DE10033717A1 (de) * 2000-07-12 2002-01-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung zur Beseitigung von Sebum
US7435429B2 (en) 2002-02-07 2008-10-14 Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US7879365B2 (en) 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
AU2003216213B2 (en) 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7563461B2 (en) * 2002-02-07 2009-07-21 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
AU2003284337B2 (en) * 2002-10-25 2010-04-15 Precision Dermatology, Inc. Modulation of zinc levels to improve tissue properties
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
TWI228051B (en) 2003-05-19 2005-02-21 Well Being Biochemical Corp Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
US20060246148A1 (en) 2003-07-29 2006-11-02 Well-Being Biochemical Corp. Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
CN102319409A (zh) 2003-07-17 2012-01-18 纽约市哥伦比亚大学托管会 含有季铵化合物及精油和/或精油成分的协同组合的抗微生物组合物
EP1576880A1 (en) * 2004-03-16 2005-09-21 Well-being Biochemical Corp. Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
US20070034118A1 (en) * 2005-08-12 2007-02-15 Jardine Leslie A Dosage efficient, storage stable compositions for reducing chromium (VI) in cement
GB0715141D0 (en) * 2007-08-03 2007-09-12 York Pharma Plc Improving skin barrier function
EP2408428B1 (en) * 2009-03-16 2016-11-09 Visions Marketing Group, Inc. Germicidal composition
EP2283805A1 (en) 2009-07-28 2011-02-16 Sirvis BV Compositions comprising a zinc containing compound dissolved in a hydrophobic phase
US20130236521A1 (en) * 2012-03-08 2013-09-12 Herpx Llc SnF2 APPLICATIONS, METHODS AND RELATED FORMULATIONS
BR112015011299A2 (pt) * 2012-11-20 2017-07-11 Onconox Aps saquinavir-no para imunomodulação
AU2012397263B2 (en) 2012-12-19 2015-09-24 Colgate-Palmolive Company Zinc amino acid halide mouthwashes
US9498421B2 (en) 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
CN104853723B (zh) 2012-12-19 2017-12-08 高露洁-棕榄公司 包含锌‑氨基酸络合物的口腔凝胶
EP2934695B1 (en) 2012-12-19 2016-11-30 Colgate-Palmolive Company Antiperspirant products with protein and antiperspirant salts
KR20150097493A (ko) * 2012-12-19 2015-08-26 콜게이트-파아므올리브캄파니 4 염기성 아연 아미노산 할로겐화물 착물과 시스테인을 함유하는 2 성분 조성물
BR112015014453B1 (pt) 2012-12-19 2019-06-11 Colgate-Palmolive Company Composição para higiene oral, complexo iônico, usos de um haleto de zinco tetrabásico em conjunto com trimetilglicina na forma de sal de adição de ácido e complexo
US10188112B2 (en) 2012-12-19 2019-01-29 Colgate-Palmolive Company Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
AU2012397259B2 (en) 2012-12-19 2015-09-17 Colgate-Palmolive Company Zinc-lysine complex
US9750670B2 (en) 2012-12-19 2017-09-05 Colgate-Palmolive Company Zinc amino acid complex with cysteine
BR112015014501B1 (pt) 2012-12-19 2019-04-02 Colgate-Palmolive Company Composição de cuidado pessoal para aplicação na pele ou cabelo e uso de um complexo de halogeneto de zinco X
AU2012397266B2 (en) 2012-12-19 2015-09-24 Colgate-Palmolive Company Oral care products comprising a tetrabasic zinc - amino acid - halide complex
EP2934445B1 (en) 2012-12-19 2017-10-04 Colgate-Palmolive Company Teeth whitening methods, visually perceptible signals and compositions therefor comprising zinc amino acid halides
US9504858B2 (en) 2012-12-19 2016-11-29 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
WO2014098829A1 (en) 2012-12-19 2014-06-26 Colgate-Palmolive Company Oral care products comprising zinc oxide and trimethylglycine
MX352558B (es) 2012-12-19 2017-11-29 Colgate Palmolive Co Composiciones para el cuidado oral que contienen halogenuros de aminoácido de zinc.
RU2638791C2 (ru) 2012-12-19 2017-12-15 Колгейт-Палмолив Компани Композиция с галогенидными предшественниками аминокислоты/триметилглицина цинка
US9675823B2 (en) 2012-12-19 2017-06-13 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
MX370240B (es) 2015-12-30 2019-12-06 Colgate Palmolive Co Composiciones para el cuidado personal.
CN108472208B (zh) * 2015-12-30 2021-12-10 高露洁-棕榄公司 个人护理组合物
JP7058343B2 (ja) * 2018-03-29 2022-04-21 ザ プロクター アンド ギャンブル カンパニー 歯肉健康を促進するための口腔ケア組成物
CN109381357B (zh) * 2018-12-13 2021-09-03 广州宝莱生物科技有限公司 一种祛痘润肤水蛭冻干粉
BR112022004344A2 (pt) 2019-09-30 2022-05-31 Procter & Gamble Composições dentifrícias para o tratamento de biofilme dental
US20210093549A1 (en) 2019-09-30 2021-04-01 The Procter & Gamble Company Fluoride-Free Anticavity Oral Care Compositions
WO2021062607A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company Oral care compositions comprising hops beta acid and amino acid
WO2021062631A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company Dentifrice compositions for treatment of dental biofilm

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2749213A (en) * 1952-07-03 1956-06-05 American Home Prod Stannous fluoro complex salts
US3282792A (en) * 1964-01-09 1966-11-01 Bristol Myers Co Stabilized stannous fluoride dentifrice compositions
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4267164A (en) * 1980-01-31 1981-05-12 Block Drug Company Inc. Effervescent stannous fluoride tablet
AU548560B2 (en) * 1980-05-20 1985-12-19 Vipont Laboratories Inc. Benzophenanthridine alkaloids as antimicrobial agents
US4406881A (en) * 1980-05-20 1983-09-27 Vipont Laboratories Antimicrobial agent
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
US4469674A (en) * 1981-09-03 1984-09-04 Richardson-Vicks Inc. Stable oral compositions containing zinc and fluoride compounds
US4415590A (en) * 1982-04-26 1983-11-15 Betamed Pharmaceuticals, Inc. Herpes treatment
US4419346A (en) * 1982-08-13 1983-12-06 Nabisco Brands, Inc. Method and composition to inhibit the growth of Streptococcus mutans by the use of saccharin/fluoride combination
US4431631A (en) * 1983-01-03 1984-02-14 Colgate-Palmolive Company Aqueous oral solution
US4568540A (en) * 1984-04-18 1986-02-04 Johnson & Johnson Oral hygiene compositions
US4684528A (en) * 1984-06-11 1987-08-04 Godfrey Science & Design, Inc. Flavor of zinc supplements for oral use
US4664906A (en) * 1984-08-30 1987-05-12 Johnson & Johnson Products Inc. Oral compositions
US4684517A (en) * 1985-02-04 1987-08-04 Colgate-Palmolive Company Mouthrinse composition containing hydrogen peroxide and fluoride
US4765984A (en) * 1986-01-22 1988-08-23 Colgate-Palmolive Company Stable single unit dose oral product
US4952392A (en) * 1986-03-17 1990-08-28 Peri-Oral Dental Products, Inc. Use of periwinkle in oral hygiene
US5004597A (en) * 1987-09-14 1991-04-02 The Procter & Gamble Company Oral compositions comprising stannous flouride and stannous gluconate
US5098716A (en) * 1990-08-23 1992-03-24 Embro William J Method and composition for treating diseases having a viral etiology
US5094845A (en) * 1991-03-04 1992-03-10 David G. Vlock Oral compositions containing zinc gluconate complexes
US5416075A (en) * 1993-11-30 1995-05-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Biospecific emulsions
WO1995026134A1 (en) * 1994-03-28 1995-10-05 The Trustees Of Columbia University In The City Of New York Composition for inactivating irritants in fluids
EP0691124A1 (en) * 1994-07-07 1996-01-10 Sara Lee/DE N.V. Mouth care products
CN1115620A (zh) * 1994-07-26 1996-01-31 袁升彪 婴幼儿童饮用水
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
DE69528445D1 (de) * 1994-12-12 2002-11-07 Unilever Nv Anti-mikrobielles Mittel
US5658946A (en) * 1996-05-29 1997-08-19 The Procter & Gamble Company Methods for the treatment of herpes virus infections
US5908640A (en) * 1997-07-25 1999-06-01 Embro; William J. Veterinary compositions for treating epidermal irritations

Also Published As

Publication number Publication date
NZ509227A (en) 2003-08-29
DE69940508D1 (de) 2009-04-16
JP2002517411A (ja) 2002-06-18
WO1999063816A1 (en) 1999-12-16
EP1085804B1 (en) 2009-03-04
IL140095A (en) 2005-11-20
US6605289B1 (en) 2003-08-12
CA2334344C (en) 2005-08-16
IL140095A0 (en) 2002-02-10
AU4558399A (en) 1999-12-30
ATE424109T1 (de) 2009-03-15
US20040042978A1 (en) 2004-03-04
ES2323395T3 (es) 2009-07-14
EA200100015A1 (ru) 2001-06-25
TR200003674T2 (tr) 2001-07-23
EP1085804A4 (en) 2005-09-28
CA2334344A1 (en) 1999-12-16
EA003463B1 (ru) 2003-06-26
ZA200100137B (en) 2001-07-10
EP1085804A1 (en) 2001-03-28
CN1311628A (zh) 2001-09-05
AU760870B2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
BR9910981A (pt) Composição e uso da mesma para o tratamento de irritações e infeções epidérmicas
CY1116988T1 (el) Βητα-l-2'-δεοξυ-νουκλεοζιτες για την θεραπεια ηπατιτιδας β
GR1002807B (el) Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
DE69313126D1 (de) Mundwasserkonzentrat zur wirksamen abgabe antimikrobieller mittel
PT806933E (pt) Formulacoes e metodos para reduzir irritacoes da pele
BR9712491A (pt) Composições cosméticas
CZ20011581A3 (cs) Systém pro podávání bioaktivní sloučeniny inhalací
MX9502035A (es) Utilizacion de los compuestos antifungicos y de los compuestos antibacterianos halogenados para la obtencion de composiciones cosmeticas para disminuir o evitar la caida del cabello.
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
DK0750901T3 (da) Oral sammensætning med forbedret optag og tilbageholdelse af antibakterielle forbindelser på dentale vævsoverflader
ATE193973T1 (de) Gegen zahnbelag, gingivitis und karies wirkende orale zusammensetzung
AU2001262401A1 (en) Use of ellagic acid as anti-pollution cosmetic agent
PT1056343E (pt) Formulacoes aquosas de parasiticidas para aplicacao dermica
TR200000620T2 (tr) 6.9-Köprülü eritromisin türevleri.
BR9406594A (pt) Formulação tópica e processos para sua preparação e para o tratamento e prevenção de parasitas internos e externos de animais
ID16662A (id) Senyawa antibakteri karbapenem komposisi yang mengandung senyawa tersebut serta metode pengobatannya
BR9712993A (pt) Composições orais contendo gluconato estanoso.
DK0692246T3 (da) Anvendelse af orale sammensætninger til reduktion af plakdannelse på tænderne
BR9808028A (pt) Composição biocida e uso da mesma.
DK1058536T3 (da) Sammensætninger med reduceret hudirritation
ATE168004T1 (de) Juckreizstillendes mittel
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
BR9915292A (pt) Associação, utilização de riluzol e composição farmacêutica.
DE69013477D1 (de) Mittel gegen juckreiz.
AU3306997A (en) Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MARTIN UNGER (CA)

Free format text: TRANSFERIDO DE: WILLIAM J. EMBRO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL. : A01N 25/00.

Ipc: A61K 31/191 (2006.01), A61K 33/16 (2006.01), A61K

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2159 DE 22/05/2012.